How does age alter osteoporosis evaluation strategies?

• A. Younger patients require more aggressive testing
• B. Evaluation focuses on medication side effects
• C. Older age increases fracture risk and shifts focus to BMD, secondary causes, fall risk, and comorbidity management
• D. Age has no effect on evaluation strategy

Answer: (C)

As people age, fracture risk increases due to progressive bone loss and the accumulation of other health factors. Because older individuals are more vulnerable to fragility fractures, the evaluation strategy shifts to quantify bone density, identify conditions or medications that worsen bone loss, and address factors that lead to falls. Measuring bone mineral density (BMD) with a DXA scan becomes central to determine osteoporosis status and overall fracture risk. Alongside this, there’s a stronger emphasis on screening for secondary causes of osteoporosis—such as endocrine disorders, malnutrition, or chronic illnesses—that may be contributing to bone weakness.

Falls become a primary concern, so the evaluation also includes assessing fall risk and functional status, reviewing vision and gait, and considering home safety and balance- or strength-building interventions. Managing comorbidities and reviewing medications that can affect bone health are important parts of the plan because older adults often have multiple health issues and take several drugs that can influence fracture risk. While medications that treat osteoporosis are considered when appropriate, the overarching approach in older patients centers on BMD assessment, investigation of secondary causes, fall prevention, and holistic comorbidity management.